Učitavanje...
Rivastigmine improves dual-task gait velocity in patients with Alzheimer’s disease
BACKGROUND: Gait impairments are common in patients with Alzheimer’s disease. Cholinesterase inhibitors are used to treat the symptoms of patients with Alzheimer’s disease, but they have not been shown to reduce the severity of Alzheimer’s disease-related gait disorders. METHODS: This was a prospect...
Spremljeno u:
| Izdano u: | BMC Neurol |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7874473/ https://ncbi.nlm.nih.gov/pubmed/33568083 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-021-02098-8 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|